2018 annual financial data
Ultragenyx Pharmaceutical 2018 Operating margin
Direct answer
Operating margin was -721.18%.
Operating income was -371,373,000 USD and net income was -197,611,000 USD.
Operating cash flow was -290,566,000 USD.
Get free Ultragenyx Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 51,495,000 USD
- Operating income
- -371,373,000 USD
- Net income
- -197,611,000 USD
- Operating cash flow
- -290,566,000 USD